EGFR is one of the prominent hallmarks of triple negative breast cancer (TNBC) and/or BPBC and over-expression of EGFR has been used as a main therapeutic target for treatment of TNBC [36], [37], [38]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.